(Maciej Frolow/Stone/Getty Images) The origins of Alzheimer's remain contentious, but a new study suggests the disease may ...

Researchers have developed a novel compound that could transform the way we treat Alzheimer's disease, offering not just a ...

For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their ...

In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...

Scientists may have sniffed out a breakthrough when detecting Alzheimer’s. The degenerative disease, which affects millions ...

Autopsy shows widespread amyloid and tau in patient who received contaminated biological m ...

Campbell: Welcome to "Beyond Diagnosis," where we talk with doctors about talking with patients. I'm your host, Glenn ...

A simple nasal swab may offer an unexpected window into the earliest biological signals of Alzheimer’s disease.

Alzheimer's disease is characterized by the accumulation of two proteins in the brain: amyloid-beta and tau. Tau normally ...

The National Institutes of Health has renewed support for Artificial Intelligence for Alzheimer's Disease, or AI4AD. The new $12.6 million award to advance the project's next phase, AI4AD2, brings its ...

Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.

A proprietary monoclonal antibody targeting an inhibitory immune checkpoint pathway had favorable safety and tolerability in ...